Novo Nordisk nach Split WKN: A3EU6F ISIN: DK0062498333 Kürzel: NOV Forum: Aktien User: Coronaprofiteur

Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 Oral semaglutide 25 mg demonstrated significantly greater mean weight loss than orforglipron 36 mg in a population-adjusted indirect treatment comparison (ITC) using data from the OASIS 4 and ATTAIN-1 clinical trials1 Treatment with orforglipron 36 mg was associated with ~14 times higher odds of stopping medication due to GI adverse events versus oral semaglutide 25 mg in the ITC1 In a separate patient preference study, 84% of survey respondents favored the treatment profile similar to oral semaglutide 25 mg compared to that similar to orforglipron2

Deutsche Privatanleger die auf einen Boden hoffen

Was noch interessant ist: Novo hat auf der Hauptversammlung die Ermächtigung erhalten bis 2027 bis zu 10% der Aktien zurück zu kaufen. Doustdar nannte 2026 das Jahr der Transformaton. Wenn Novo nicht weiß, wann Sie Aktien kaufen sollen, wer dann?

Sehr interessant

An interesting pattern in $NVO price action. Just data. You decide what it means. During active buyback (Oct-Dec 2025): October: $59 → $49. Down 16%. November: $49 → $49. Flat. December: $48 → $51. Up 5%. During blackout / no buyback (Jan 2026): January: $52 → $64. Up 13%. The stock ROSE 13% the month Novo stopped buying. Then on February 4 — the FIRST DAY of the new buyback programme — Novo published guidance of -5% to -13% sales decline. The stock crashed 15% that day. From $59 to $43. The new DKK 3.8B buyback tranche started buying immediately. At $43. Then $38. Then $36. Average buyback prices tell the story: Feb 4-27: DKK 286.95 per share Feb 4 - Mar 20: DKK 266.53 Feb 4 - Mar 27: DKK 261.91 Each week, the average price drops. More shares per DKK spent. 9.16 million B shares acquired at an average of DKK 261.91. That's 20% below where the stock traded during the January blackout. Now the timeline repeats: ~April 6: Blackout begins (30 days before Q1 results May 6) April 6 - May 6: No buyback. No buying pressure. No selling pressure. May 6: Q1 results. 1.2M Wegovy pill prescriptions vs -13% guidance. If January's pattern repeats, the stock rises during the blackout. If the guidance surprise is positive, May 6 could be significant. I'm not drawing conclusions. I'm showing the pattern. The data is public. The filings are public. The prices are public. Follow the pattern. Follow the filings. $NVO #GLP1 #SNAC #buyback

Was nicht passt, wird passend gemacht. Auch der Gatte ;-)

... wenn schon der Gatte nicht passt, dann wenigstens das Hochzeitskleid.

Jamey Millar, neuer Executive VP, Novo US *** https://www.instagram.com/reel/DWpZauDjib8/?igsh=dnIzZnc4eGd6dm00

Massenmarkt in Indien? *** https://www.reuters.com/business/healthcare-pharmaceuticals/indias-mounjaro-brides-weight-loss-injections-become-part-pre-wedding-2026-04-03/

Europa nur 15%

Schöne Idee. Könnte knapp werden. Aber ich denke im Juli können wir wieder bei 45 € bis 50 € stehen

US imposes 100% pharma tariff, strengthens metal duties - baha.com https://share.google/wY5KWBj9XpYHqtYQ2

ich will 75 bis juli

War natürlich ironisch gemeint.

Das klingt nicht gerade realistisch.

Meiner Prognose nach geht es auf 2€ und dann kommt ein fetter rebound auf 2000€! Abwarten!